Myositis-specific antibodies (MSAs) are associated with certain symptoms in JM patients. In some cases, knowing the MSA of a patient may help clinicians look out for certain symptoms and guide treatment decisions. Dr. Jessica Neely explains these associations, why they are important, and the limitations in our understanding of the role of MSAs in JM.
Join Cure JM and receive invitations to our monthly Town Halls.
Hear from a variety of speakers on topics of interest to Cure JM families, including information on the JDM basics, new treatments, the latest, research updates, and other support available to JM families.